Halozyme Therapeutics (HALO) Price to Earnings (2017 - 2026)
Halozyme Therapeutics' (HALO) Price to Earnings was 21.58 for Q2 2026, up 96.6% from 10.98 a year earlier but down 1.7% from the prior quarter.
Powered by 
Analysis
Halozyme Therapeutics (HALO) Price to Earnings (2017 - 2026) Analysis & Trends
For FY2025, Price to Earnings at Halozyme Therapeutics was 25.01, up 88.7% from FY2024.
- By year, Price to Earnings came in at 13.26 in FY2024 (-20.3%), 16.64 in FY2023 (-56.3%), 38.05 in FY2022 (+176.3%) and 13.77 in FY2021 (-69.6%).
- Five-year quarterly Price to Earnings spans a low of 10.98 in Q2 2025 and a high of 38.05 in Q4 2022.
- Year over year, Price to Earnings has now increased in each of the last three quarters, with growth averaging 15.9% over the last eight quarters.
- The high point for year-over-year Price to Earnings in five years was Q4 2022 (growth of 176.3%); the low point was Q3 2021 (a decline of 91.5%).
- Per Business Quant data, the three quarters before Q2 2026 came in at 21.96 (Q1 2026), 25.01 (Q4 2025) and 14.47 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Halozyme Therapeutics | 12.53 Bn | 11.13 Bn | 401.83 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 21.58 |
| Mar 31, 2026 | 21.96 |
| Dec 31, 2025 | 25.01 |
| Sep 30, 2025 | 14.47 |
| Jun 30, 2025 | 10.98 |
| Mar 31, 2025 | 16.19 |
| Dec 31, 2024 | 13.26 |
| Sep 30, 2024 | 18.55 |
| Jun 30, 2024 | 19.64 |
| Mar 31, 2024 | 16.23 |
| Dec 31, 2023 | 16.64 |
| Sep 30, 2023 | 19.87 |
| Jun 30, 2023 | 20.35 |
| Mar 31, 2023 | 27.68 |
| Dec 31, 2022 | 38.05 |
| Sep 30, 2022 | 25.31 |
| Jun 30, 2022 | 16.55 |
| Mar 31, 2022 | 12.64 |
| Dec 31, 2021 | 13.77 |
| Sep 30, 2021 | 14.02 |
API Access
Halozyme Therapeutics Price to Earnings API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-earnings&ticker=HALO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-earnings", "ticker": "HALO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=price-to-earnings&ticker=HALO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();